Concepedia
Statistics
Publications
34
Citations
1.4K
H-Index
23
Active since
1987
Affiliations
University of Surrey(Current)
GlaxoSmithKline (United Kingdom)
Drexel University
Research Triangle Park Foundation
GlaxoSmithKline (United States)
Andrew D. Ayrton is an author at University of Surrey specializing in pharmacology, medicine, and biochemistry.
Publications per year
1987–2012
Preclinical Strategy to Reduce Clinical Hepatotoxicity Using in Vitro Bioactivation Data for >200 Compounds
Melanie Z. Sakatis, Melinda J. Reese, Andrew W. Harrell et al. · Chemical Research in Toxicology · 2012 · 121 citations
Pharmacy, Pharmacology, Toxicology +17
Pyrimidinylimidazole inhibitors of CSBP/P38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes
Jerry L. Adams, Jeffrey C. Boehm, Shouki Kassis et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 113 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +16
Use of a reporter gene assay to predict and rank the potency and efficacy of CYP3A4 inducers.
Wafaa El-Sankary, G. Gordon Gibson, Andrew D. Ayrton et al. · PubMed · 2001 · 105 citations
Life Sciences, Molecular Biology, Pharmacology +13
Biopharmaceutics Classification System: Validation and Learnings of an in Vitro Permeability Assay
Victoria E. Thiel-Demby, Joan E. Humphreys, Lisa Williams et al. · Molecular Pharmaceutics · 2008 · 95 citations
Pharmacy, Pharmaceutics, Pharmacology +17
Exact kinetic analysis of passive transport across a polarized confluent MDCK cell monolayer modeled as a single barrier
Thuy Tran, Tracy L. Gales, Beverly E. Maleeff et al. · Journal of Pharmaceutical Sciences · 2004 · 72 citations
Engineering, Cell Biology, Biological Transport Phenomena +15
1–5 of 34